Summary
- Current Price
- As of today, COGT price is $37.34, down -2.61% on
- Current Price All-Time High
- COGT price is currently -47.14% below its historical high of $70.64 set on
- Market Cap
- COGT current market cap is $6B, up +541.41% over the past 365 days
- PE Ratio
- COGT PE ratio is unknown
- Revenue
- COGT current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for COGT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Cogent Biosciences, Inc. |
| Ticker | NASDAQ: COGT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cogentbio.com |
| Employees | 205 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $37.34 | |
| Price, 1D Change | -2.61% | |
| $6B | ||
| - | ||
| - | ||
| 1.90 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$2.55 | ||
| EPS, 1Y Change | -3.61% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:4 | |
| Next Split | N/A | N/A |
| Last Ticker Change | UMRX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.55 | ||
| EPS Estimate | N/A | -$2.13 |
| EPS Est. Change | N/A | +16.50% |
| $0.00 | ||
| Revenue Estimate | N/A | $20.08M |
| Revenue Est. Change | N/A | - |
| Current Price | $37.34 | |
| Price Target | - | $53.50 |
| Price Tgt. Change | - | +43.28% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.40 | -$2.46 | -2.48% | |
| -$2.23 | -$2.55 | -14.34% | |
| -$2.13 | N/A | +16.50% | |
| -$0.61 | N/A | +75.91% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $20.08M | N/A | - | |
| $350.60M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $37.34 | |
| $20.25 | ||
| SMA 200 vs Price | -45.78% | |
| $37.79 | ||
| SMA 50 vs Price | +1.21% | |
| 1.90 | ||
| $1.92 | ||
| 49.81 | ||
| 34.36% | ||
| 137.24% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$2.55 | ||
| $0.00 | ||
| - | ||
| -$333.36M | ||
| - | ||
| -$328.94M | ||
| - | ||
| -$328.74M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 14.23 | ||
| 14.23 | ||
| - | ||
| - | ||
| 9.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 10.48 | ||
| -15.42 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $546.98M | ||
| $900.77M | ||
| $937.61M | ||
| $910.36M | ||
| $301.24M | ||
| $63.95M | ||
| $238.80M | ||
| $1.55M | ||
| $9.50M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $328.94M | ||
| $333.36M | ||
| $0.00 | ||
| $0.00 | ||
| $4.58M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$264.44M | ||
| -$399.53M | ||
| $878.23M | ||
| $1.55M | ||
| -$266.00M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Piper Sandler | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Baird | → | |
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with COGT
FAQ
What is the ticker symbol for Cogent Biosciences, Inc.?
The ticker symbol for Cogent Biosciences, Inc. is NASDAQ:COGT
Does Cogent Biosciences, Inc. pay dividends?
No, Cogent Biosciences, Inc. does not pay dividends
What sector is Cogent Biosciences, Inc. in?
Cogent Biosciences, Inc. is in the Healthcare sector
What industry is Cogent Biosciences, Inc. in?
Cogent Biosciences, Inc. is in the Biotechnology industry
What country is Cogent Biosciences, Inc. based in?
Cogent Biosciences, Inc. is headquartered in United States
When did Cogent Biosciences, Inc. go public?
Cogent Biosciences, Inc. initial public offering (IPO) was on March 29, 2018
Is Cogent Biosciences, Inc. in the S&P 500?
No, Cogent Biosciences, Inc. is not included in the S&P 500 index
Is Cogent Biosciences, Inc. in the NASDAQ 100?
No, Cogent Biosciences, Inc. is not included in the NASDAQ 100 index
Is Cogent Biosciences, Inc. in the Dow Jones?
No, Cogent Biosciences, Inc. is not included in the Dow Jones index
When was Cogent Biosciences, Inc. last earnings report?
Cogent Biosciences, Inc.'s most recent earnings report was on February 17, 2026
When does Cogent Biosciences, Inc. report earnings?
The next expected earnings date for Cogent Biosciences, Inc. is May 5, 2026
Data Sources & References
- COGT Official Website www.cogentbio.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1622229/000119312526053334/0001193125-26-053334-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1622229/000119312526053334/0001193125-26-053334-index.htm
- COGT Profile on Yahoo Finance finance.yahoo.com/quote/COGT
- COGT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cogt